# Evotec SE

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evotec-se

- Industry: Pharmaceuticals
- Headquarters: Hamburg, Germany
- Website: www.evotec.com
- Total disclosed funding: $31M
- Latest round: Series A (Apr 2, 2004)
- Investors on record: 5

## About

Evotec SE is a biotechnology company founded in 1993 and headquartered in Hamburg, Germany. The company specializes in drug discovery and development services, adapting its business strategies to meet evolving market demands. Rudolf Rigler, a pivotal figure in its establishment, led the company through various phases of growth. In May 2025, Evotec SE agreed to acquire Fortaco Gruza from Fortaco Group Oy. 
Evotec is a biotechnology company that specializes in research and development (R&D) services aimed at addressing unmet medical needs across various therapeutic areas. Its core offerings include high-value pipeline co-creation partnerships and comprehensive Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services. These services accelerate drug development processes from initial disease understanding through to Investigational New Drug (IND) submission and Phase 1 clinical trials. Evotec's expertise extends particularly to small molecules and biotherapeutics, leveraging advanced technologies such as artificial intelligence and continuous manufacturing to enhance the quality and accessibility of high-quality therapeutics. The company collaborates with a diverse range of clients, including pharmaceutical and biotechnology firms, primarily operating in markets across Europe, North America, and parts of Asia, seeking innovative solutions to advance their drug discovery and development efforts.

## Funding rounds

- Series A, Apr 2, 2004, $31M — 3i, MVM Partners, STAR Ventures, Ventech, TVM Capital Life Science

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series A
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series A
- STAR Ventures — Series A
- Ventech (https://capitalatlas.ai/funds/ventech) — Series A
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A